15-2-2013

:

,
!
15 February 2013
by

:

.

:


.

.

,
. ,

.
,

Impact of pharmacy deregulation and regulation in European countries (Authors:
Sabine Vogler, Danielle Arts, Katharina
Sandberger, Gesundheit sterreichGmbH / Geschftsbereich BIG WHO Collaborating Centre
for Pharmaceutical Pricing and Reimbursement Policies)

.
: 2012 9
5
(, , , ) 4
(, , )
15
(accessibility), (availability), (quality)
(economics)
. (sections 1, 2 Methodology)
.

.

,

.

15-2-2013

. (. s 2 Results, Conclusions)
:

(access) .
.
(. , ) (clustering)
( )
. ( sections 3.2.1 4.1 4.2)

,
(predominantly available)

(not held in stock for profit reasons)

. ( sections3.2.1 4.2)

. ( 4.2)

.


(. ) (.
) ( 3.2.2 4.3)

.
.

. ( 3.2.2 4.3 4.5)

. 1 3
(
!)

.

. (Deregulation in the community pharmacy sector has no direct impact on a
countrys pharmaceutical, including public, expenditure)
. ( 3.2.3 4.4)

. ( 4.4)

.

. ( 4.2 4.5)

15-2-2013

. ( 4.6)
:
,

. ( 4.6 4.7)


, . ( 4.7)

.

http://koutepas.hellenic-pharmacy.com/?p=230